{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:04:35Z","timestamp":1789635875504,"version":"4.0.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058575"],"award-info":[{"award-number":["R21DA058575"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["6NU62PS924778"],"award-info":[{"award-number":["6NU62PS924778"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5NU62PS924762"],"award-info":[{"award-number":["5NU62PS924762"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["6NU62PS924771"],"award-info":[{"award-number":["6NU62PS924771"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU62PS924764"],"award-info":[{"award-number":["NU62PS924764"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10461-026-05034-4","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:53:29Z","timestamp":1770904409000},"page":"2658-2669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-7206","authenticated-orcid":false,"given":"Vanessa M.","family":"McMahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-218X","authenticated-orcid":false,"given":"Courtney","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-6719","authenticated-orcid":false,"given":"Alia","family":"Al-Tayyib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-6533","authenticated-orcid":false,"given":"Yingbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-5660","authenticated-orcid":false,"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-8358","authenticated-orcid":false,"given":"Ekow Kwa","family":"Sey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-495X","authenticated-orcid":false,"given":"Erin C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-823X","authenticated-orcid":false,"given":"Albert Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-6570","authenticated-orcid":false,"given":"Phillip O.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-3083","authenticated-orcid":false,"given":"Sara N.","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"12","key":"5034_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","volume":"1","author":"B Han","year":"2021","unstructured":"Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use Disorder, and associated overdose deaths among US adults. JAMA Psychiatry Dec. 2021;1(12):1329\u201342. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2588.","journal-title":"JAMA Psychiatry Dec"},{"issue":"1","key":"5034_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14688","volume":"1508","author":"CM Jones","year":"2022","unstructured":"Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the united states: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci Feb. 2022;1508(1):3\u201322. https:\/\/doi.org\/10.1111\/nyas.14688.","journal-title":"Ann N Y Acad Sci Feb"},{"key":"5034_CR3","unstructured":"Center for Behavioral Health Statistics and Quality. 2021\u20132022 National Survey on Drug Use and Health National Maps of Prevalence Estimates, by State."},{"key":"5034_CR4","unstructured":"Center for Behavioral Health Statistics and Quality. 2016 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD September 7, 2017."},{"key":"5034_CR5","unstructured":"Center for Behavioral Health Statistics and Quality. Results from the 2023 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD July 2024."},{"issue":"4","key":"5034_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJMra2033007","volume":"22","author":"WM Compton","year":"2021","unstructured":"Compton WM, Jones CM. Substance use among men who have sex with men. N Engl J Med Jul. 2021;22(4):352\u20136. https:\/\/doi.org\/10.1056\/NEJMra2033007.","journal-title":"N Engl J Med Jul"},{"issue":"1","key":"5034_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13011-022-00453-7","volume":"9","author":"S Moradi","year":"2022","unstructured":"Moradi S, Moradi Y, Rahmani K, Nouri B, Moradi G. The association between methamphetamine use and number of sexual partners in men who have sex with men: a systematic review and meta-analysis. Subst Abuse Treat Prev Policy Apr. 2022;9(1):27. https:\/\/doi.org\/10.1186\/s13011-022-00453-7.","journal-title":"Subst Abuse Treat Prev Policy Apr"},{"issue":"6","key":"5034_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s10461-011-0131-8","volume":"16","author":"HW Vosburgh","year":"2012","unstructured":"Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav Aug. 2012;16(6):1394\u2013410. https:\/\/doi.org\/10.1007\/s10461-011-0131-8.","journal-title":"AIDS Behav Aug"},{"issue":"1 Suppl 1","key":"5034_CR9","doi-asserted-by":"publisher","first-page":"i62","DOI":"10.1093\/jurban\/jti025","volume":"82","author":"G Colfax","year":"2005","unstructured":"Colfax G, Coates TJ, Husnik MJ, et al. Longitudinal patterns of methamphetamine, Popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health Mar. 2005;82(1 Suppl 1):i62\u201370. https:\/\/doi.org\/10.1093\/jurban\/jti025.","journal-title":"J Urban Health Mar"},{"issue":"2","key":"5034_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/sti.2005.017129","volume":"82","author":"G Mansergh","year":"2006","unstructured":"Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect Apr. 2006;82(2):131\u20134. https:\/\/doi.org\/10.1136\/sti.2005.017129.","journal-title":"Sex Transm Infect Apr"},{"issue":"4","key":"5034_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/01.olq.0000194595.90487.ed","volume":"33","author":"DD Brewer","year":"2006","unstructured":"Brewer DD, Golden MR, Handsfield HH. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sex Transm Dis Apr. 2006;33(4):250\u20135. https:\/\/doi.org\/10.1097\/01.olq.0000194595.90487.ed.","journal-title":"Sex Transm Dis Apr"},{"issue":"5","key":"5034_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.aids.0000216374.61442.55","volume":"20","author":"BA Koblin","year":"2006","unstructured":"Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20(5):731\u20139. https:\/\/doi.org\/10.1097\/01.aids.0000216374.61442.55.","journal-title":"AIDS"},{"issue":"1","key":"5034_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/QAI.0b013e3180417c99","volume":"45","author":"MW Plankey","year":"2007","unstructured":"Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007;45(1):85\u201392. https:\/\/doi.org\/10.1097\/QAI.0b013e3180417c99.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5034_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugpo.2017.12.010","volume":"55","author":"J Bryant","year":"2018","unstructured":"Bryant J, Hopwood M, Dowsett GW, et al. The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. Int J Drug Policy. 2018;55:242\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2017.12.010.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"5034_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00406-024-01856-2","volume":"275","author":"J Schwarz","year":"2025","unstructured":"Schwarz J, Gertzen M, Rabenstein A, et al. What chemsex does to the brain - neural correlates (ERP) regarding decision making, impulsivity and hypersexuality. Eur Arch Psychiatry Clin Neurosci. 2025;275(1):227\u201340. https:\/\/doi.org\/10.1007\/s00406-024-01856-2.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"5034_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/sextrans-2016-052695","volume":"93","author":"P Weatherburn","year":"2017","unstructured":"Weatherburn P, Hickson F, Reid D, Torres-Rueda S, Bourne A. Motivations and values associated with combining sex and illicit drugs ('chemsex\u2019) among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2017;93(3):203\u20136. https:\/\/doi.org\/10.1136\/sextrans-2016-052695.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"5034_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10508-007-9292-y","volume":"38","author":"SJ Semple","year":"2009","unstructured":"Semple SJ, Zians J, Strathdee SA, Patterson TL. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav. 2009;38(4):583\u201390. https:\/\/doi.org\/10.1007\/s10508-007-9292-y.","journal-title":"Arch Sex Behav"},{"issue":"3","key":"5034_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/QAI.0000000000002461","volume":"85","author":"C Grov","year":"2020","unstructured":"Grov C, Westmoreland D, Morrison C, Carrico AW, Nash D. The crisis we are not talking about: one-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users. J Acquir Immune Defic Syndr. 2020;85(3):272\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002461.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5034_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.drugalcdep.2018.06.017","volume":"190","author":"LMC Nerlander","year":"2018","unstructured":"Nerlander LMC, Hoots BE, Bradley H, Broz D, Thorson A, Paz-Bailey G. HIV infection among MSM who inject methamphetamine in 8 US cities. Drug Alcohol Depend. 2018;190:216\u201323. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.017.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5034_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1071\/SH18060","volume":"16","author":"VM McMahan","year":"2019","unstructured":"McMahan VM, Martin A, Garske L, et al. Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use methamphetamine in Seattle (WA, USA). Sex Health. 2019;16(2):139\u201347. https:\/\/doi.org\/10.1071\/SH18060.","journal-title":"Sex Health"},{"issue":"4","key":"5034_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/OLQ.0000000000001128","volume":"47","author":"VM McMahan","year":"2020","unstructured":"McMahan VM, Moreno C, Al-Tayyib A, et al. Pre-exposure prophylaxis awareness and use among cisgender men who have sex with men and use methamphetamine in 3 Western US cities. Sex Transm Dis. 2020;47(4):217\u201323. https:\/\/doi.org\/10.1097\/OLQ.0000000000001128.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"5034_CR22","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10461-024-04308-z","volume":"28","author":"B Suprasert","year":"2024","unstructured":"Suprasert B, Tate M, Reagan D, et al. Continuing low awareness and use of pre-exposure prophylaxis (PrEP) for HIV among people who inject drugs (PWID), San Francisco, 2022. AIDS Behav. 2024;28(6):2089\u2013100. https:\/\/doi.org\/10.1007\/s10461-024-04308-z.","journal-title":"AIDS Behav"},{"issue":"5","key":"5034_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490\u2013506. https:\/\/doi.org\/10.1007\/s10461-020-02988-x.","journal-title":"AIDS Behav"},{"issue":"4","key":"5034_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","volume":"18","author":"KB Biello","year":"2021","unstructured":"Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The past, present, and future of PrEP implementation among people who use drugs. Curr HIV AIDS Rep. 2021;18(4):328\u201338. https:\/\/doi.org\/10.1007\/s11904-021-00556-z.","journal-title":"Curr HIV AIDS Rep"},{"issue":"7","key":"5034_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/qad.0000000000000613","volume":"29","author":"M Martin","year":"2015","unstructured":"Martin M, Vanichseni S, Suntharasamai P, et al. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015;29(7):819\u201324. https:\/\/doi.org\/10.1097\/qad.0000000000000613.","journal-title":"AIDS"},{"issue":"6","key":"5034_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11121-017-0799-8","volume":"18","author":"ED Storholm","year":"2017","unstructured":"Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737\u201347. https:\/\/doi.org\/10.1007\/s11121-017-0799-8.","journal-title":"Prev Sci"},{"issue":"1","key":"5034_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1071\/SH19083","volume":"17","author":"VM McMahan","year":"2020","unstructured":"McMahan VM, Violette LR, Andrasik MP, Martin A, Garske L, Stekler JD. I make sure my doctor doesn\u2019t know that i use meth\u2019: perceived barriers to pre-exposure prophylaxis (PrEP) uptake among community peer educators in Seattle (WA, USA). Sex Health. 2020;17(1):29\u201337. https:\/\/doi.org\/10.1071\/SH19083.","journal-title":"Sex Health"},{"issue":"7","key":"5034_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10461-016-1370-5","volume":"20","author":"JT Parsons","year":"2016","unstructured":"Parsons JT, Rendina HJ, Whitfield TH, Grov C. Familiarity with and preferences for oral and long-acting injectable HIV pre-exposure prophylaxis (PrEP) in a national sample of gay and bisexual men in the U.S. AIDS Behav. 2016;20(7):1390\u20139. https:\/\/doi.org\/10.1007\/s10461-016-1370-5.","journal-title":"AIDS Behav"},{"key":"5034_CR29","unstructured":"Sanchez T, Rai M, Beckham SW et al. High Interest in Long-Acting Injectable HIV Pre-exposure Prophylaxis among Nationwide Online Sample of United States Men Who Have Sex With Men, 2019. Paper presented at: International AIDS Society Conference; July 18\u201321, 2021, 2021; Berlin, Germany."},{"key":"5034_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108058","volume":"117","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse Treat. 2020;117:108058. https:\/\/doi.org\/10.1016\/j.jsat.2020.108058.","journal-title":"J Subst Abuse Treat"},{"key":"5034_CR31","unstructured":"US Food and Drug Administration. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention."},{"key":"5034_CR32","unstructured":"Landovitz RJ, Donnell D, Clement M et al. Pre-exposure prophylaxis containing long-acting injectable cabotegravir is safe and highly effective for cisgender men and transgender women who have sex with men. Paper presented at: International AIDS Conference 2020."},{"key":"5034_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407001","author":"LG Bekker","year":"2024","unstructured":"Bekker LG, Das M, Abdool Karim Q, et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2407001.","journal-title":"N Engl J Med"},{"key":"5034_CR34","unstructured":"World Health Organization. FDA Approval of Injectable Lenacapavir Marks Progress for HIV Prevention."},{"key":"5034_CR35","unstructured":"Gilead Sciences. Gilead\u2019s twice-yearly Lenacapavir for HIV prevention reduced HIV infections by 96% and demonstrated superiority to daily Truvada in second pivotal phase 3 trial."},{"key":"5034_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/9780470753552.ch4","volume-title":"Social Psychological Foundations of Health and Illness","author":"WA Fisher","year":"2003","unstructured":"Fisher WA, Fisher JD, Harman J. The Information-Motivation-Behavioral Skills Model: A General Social Psychological Approach to Understanding and Promoting Health Behavior. In: Social Psychological Foundations of Health and Illness. 2003. p. 82\u2013106."},{"issue":"11","key":"5034_CR37","doi-asserted-by":"publisher","DOI":"10.2196\/39053","volume":"8","author":"D Kanny","year":"2022","unstructured":"Kanny D, Broz D, Finlayson T, Lee K, Sionean C, Wejnert C. A key comprehensive system for biobehavioral surveillance of populations disproportionately affected by HIV (National HIV Behavioral Surveillance): cross-sectional survey study. JMIR Public Health Surveill. 2022;8(11):e39053. https:\/\/doi.org\/10.2196\/39053.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"5034_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society\u2013USA panel. JAMA. 2023;329(1):63\u201384. https:\/\/doi.org\/10.1001\/jama.2022.22246.","journal-title":"JAMA"},{"key":"5034_CR39","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013\u20092021 Update: a clinical practice guideline."},{"issue":"1","key":"5034_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ede.0000000000001544","volume":"34","author":"D Talbot","year":"2023","unstructured":"Talbot D, M\u00e9sidor M, Chiu Y, Simard M, Sirois C. An alternative perspective on the robust Poisson method for estimating risk or prevalence ratios. Epidemiology. 2023;34(1):1\u20137. https:\/\/doi.org\/10.1097\/ede.0000000000001544.","journal-title":"Epidemiology"},{"issue":"4","key":"5034_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083837","volume":"14","author":"SW Cole","year":"2024","unstructured":"Cole SW, Glick JL, Campoamor NB, et al. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment. BMJ Open. 2024;14(4):e083837. https:\/\/doi.org\/10.1136\/bmjopen-2023-083837.","journal-title":"BMJ Open"},{"issue":"10","key":"5034_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293297","volume":"18","author":"J Fu","year":"2023","unstructured":"Fu J, Dai Z, Wang H, et al. Willingness to use long-acting injectable PrEP among HIV-negative\/unknown men who have sex with men in mainland China: a cross-sectional online survey. PLoS One. 2023;18(10):e0293297. https:\/\/doi.org\/10.1371\/journal.pone.0293297.","journal-title":"PLoS One"},{"issue":"3","key":"5034_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/coh.0000000000000734","volume":"17","author":"O Sued","year":"2022","unstructured":"Sued O, Nardi N, Spadaccini L. Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review. Curr Opin HIV AIDS. 2022;17(3):145\u201361. https:\/\/doi.org\/10.1097\/coh.0000000000000734.","journal-title":"Curr Opin HIV AIDS"},{"issue":"sup1","key":"5034_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/09540121.2024.2307378","volume":"36","author":"H Wang","year":"2024","unstructured":"Wang H, Zimmermann HML, van de Vijver D, Jonas KJ. Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach. AIDS Care. 2024;36(sup1):89\u2013100. https:\/\/doi.org\/10.1080\/09540121.2024.2307378.","journal-title":"AIDS Care"},{"issue":"7","key":"5034_CR45","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s10508-024-02886-6","volume":"53","author":"L Liu","year":"2024","unstructured":"Liu L, Ruan Y, Chen S, et al. Willingness to use long-acting injectable cabotegravir and associated factors among men who have sex with men in Guangxi, China. Arch Sex Behav. 2024;53(7):2795\u2013806. https:\/\/doi.org\/10.1007\/s10508-024-02886-6.","journal-title":"Arch Sex Behav"},{"issue":"4","key":"5034_CR46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/QAI.0b013e318293f10b","volume":"63","author":"GM Santos","year":"2013","unstructured":"Santos GM, Coffin PO, Das M, et al. Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco. J Acquir Immune Defic Syndr. 2013;63(4):540\u20134. https:\/\/doi.org\/10.1097\/QAI.0b013e318293f10b.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5034_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-025-04846-0","author":"TS Bartholomew","year":"2025","unstructured":"Bartholomew TS, Plesons M, Westmoreland DA, et al. Intravenous methamphetamine use, HIV status and PrEP uptake among a U.S. sample of 29,880 gender and sexual minorities, 2022\u20132023. AIDS Behav. 2025. https:\/\/doi.org\/10.1007\/s10461-025-04846-0.","journal-title":"AIDS Behav"},{"key":"5034_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108371","volume":"129","author":"J Jaiswal","year":"2021","unstructured":"Jaiswal J, Dunlap K, Griffin M, et al. Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: the key role of non-medical staff in enhancing HIV prevention. J Subst Abuse Treat. 2021;129:108371. https:\/\/doi.org\/10.1016\/j.jsat.2021.108371.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"5034_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26077","volume":"26","author":"P Schoenberg","year":"2023","unstructured":"Schoenberg P, Edwards OW, Merrill L, et al. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021\u20132022: cross-sectional study. J Int AIDS Soc. 2023;26(3):e26077. https:\/\/doi.org\/10.1002\/jia2.26077.","journal-title":"J Int AIDS Soc"},{"key":"5034_CR50","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report: Diagnoses, Deaths, and Prevalence of HIV in the United States and 6 Territories and Freely Associated States, 2022 05\/21\/2024."},{"key":"5034_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100738","volume":"33","author":"PS Sullivan","year":"2024","unstructured":"Sullivan PS, DuBose SN, Castel AD, et al. Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis. Lancet Reg Health Am. 2024;33:100738. https:\/\/doi.org\/10.1016\/j.lana.2024.100738.","journal-title":"Lancet Reg Health Am"},{"issue":"Suppl 2","key":"5034_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26107","volume":"26","author":"L Lorenzetti","year":"2023","unstructured":"Lorenzetti L, Dinh N, van der Straten A, et al. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023;26(Suppl 2):e26107. https:\/\/doi.org\/10.1002\/jia2.26107.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"5034_CR53","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10508-017-1049-7","volume":"47","author":"KB Biello","year":"2018","unstructured":"Biello KB, Hosek S, Drucker MT, et al. Preferences for injectable PrEP among young U.S. cisgender men and transgender women and men who have sex with men. Arch Sex Behav. 2018;47(7):2101\u20137. https:\/\/doi.org\/10.1007\/s10508-017-1049-7.","journal-title":"Arch Sex Behav"},{"issue":"9","key":"5034_CR54","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1007\/s10461-024-04384-1","volume":"28","author":"J Hill-Rorie","year":"2024","unstructured":"Hill-Rorie J, Biello KB, Quint M, et al. Weighing the options: which PrEP (Pre-exposure Prophylaxis) modality attributes influence choice for young gay and bisexual men in the United States? AIDS Behav. 2024;28(9):2970\u20138. https:\/\/doi.org\/10.1007\/s10461-024-04384-1.","journal-title":"AIDS Behav"},{"key":"5034_CR55","unstructured":"Rupa R, Patel. Promise and Pitfalls of Biomedical Prevention: Beyond Phase III. Paper presented at: Conference on Retroviruses and Opportunistic Infections; March 3\u20136, 2024; Denver, Colorado."},{"issue":"9","key":"5034_CR56","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2105\/ajph.2019.305172","volume":"109","author":"AJ Siegler","year":"2019","unstructured":"Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109(9):1216\u201323. https:\/\/doi.org\/10.2105\/ajph.2019.305172.","journal-title":"Am J Public Health"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05034-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:35:34Z","timestamp":1789634134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05034-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5034"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05034-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"8 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sara N Glick has received research funding unrelated to this project from Cepheid. There are no other financial interests to report.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}